These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
415 related articles for article (PubMed ID: 26464663)
21. FKBP4 Accelerates Malignant Progression of Non-Small-Cell Lung Cancer by Activating the Akt/mTOR Signaling Pathway. Meng W; Meng J; Jiang H; Feng X; Wei D; Ding Q Anal Cell Pathol (Amst); 2020; 2020():6021602. PubMed ID: 33354489 [TBL] [Abstract][Full Text] [Related]
22. Ghrelin promotes human non-small cell lung cancer A549 cell proliferation through PI3K/Akt/mTOR/P70S6K and ERK signaling pathways. Zhu J; Yao J; Huang R; Wang Y; Jia M; Huang Y Biochem Biophys Res Commun; 2018 Apr; 498(3):616-620. PubMed ID: 29524402 [TBL] [Abstract][Full Text] [Related]
23. A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features. Trigka EA; Levidou G; Saetta AA; Chatziandreou I; Tomos P; Thalassinos N; Anastasiou N; Spartalis E; Kavantzas N; Patsouris E; Korkolopoulou P Oncol Rep; 2013 Aug; 30(2):623-36. PubMed ID: 23728071 [TBL] [Abstract][Full Text] [Related]
24. Downregulation of TM7SF4 inhibits cell proliferation and metastasis of A549 cells through regulating the PI3K/AKT/mTOR signaling pathway. Yang X; Song X; Wang X; Liu X; Peng Z Mol Med Rep; 2017 Nov; 16(5):6122-6127. PubMed ID: 28849122 [TBL] [Abstract][Full Text] [Related]
25. Ganoderic acid DM induces autophagic apoptosis in non-small cell lung cancer cells by inhibiting the PI3K/Akt/mTOR activity. Xia J; Dai L; Wang L; Zhu J Chem Biol Interact; 2020 Jan; 316():108932. PubMed ID: 31874162 [TBL] [Abstract][Full Text] [Related]
26. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway. Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912 [TBL] [Abstract][Full Text] [Related]
27. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway. Jin H; Qiao F; Wang Y; Xu Y; Shang Y Oncol Rep; 2015 Nov; 34(5):2782-9. PubMed ID: 26351877 [TBL] [Abstract][Full Text] [Related]
28. Desumoylating Isopeptidase 2 (DESI2) Inhibits Proliferation and Promotes Apoptosis of Pancreatic Cancer Cells through Regulating PI3K/AKT/mTOR Signaling Pathway. Ou X; Zhang GT; Xu Z; Chen JS; Xie Y; Liu JK; Liu XP Pathol Oncol Res; 2019 Apr; 25(2):635-646. PubMed ID: 30411297 [TBL] [Abstract][Full Text] [Related]
29. Thymosin alpha 1 suppresses proliferation and induces apoptosis in breast cancer cells through PTEN-mediated inhibition of PI3K/Akt/mTOR signaling pathway. Guo Y; Chang H; Li J; Xu XY; Shen L; Yu ZB; Liu WC Apoptosis; 2015 Aug; 20(8):1109-21. PubMed ID: 26002438 [TBL] [Abstract][Full Text] [Related]
30. lncRNA HOXB-AS3 exacerbates proliferation, migration, and invasion of lung cancer via activating the PI3K-AKT pathway. Jiang W; Kai J; Li D; Wei Z; Wang Y; Wang W J Cell Physiol; 2020 Oct; 235(10):7194-7203. PubMed ID: 32039488 [TBL] [Abstract][Full Text] [Related]
31. Transmembrane-4 L-six family member-1 (TM4SF1) promotes non-small cell lung cancer proliferation, invasion and chemo-resistance through regulating the DDR1/Akt/ERK-mTOR axis. Ye L; Pu C; Tang J; Wang Y; Wang C; Qiu Z; Xiang T; Zhang Y; Peng W Respir Res; 2019 May; 20(1):106. PubMed ID: 31142317 [TBL] [Abstract][Full Text] [Related]
32. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells. Ma J; Sawai H; Matsuo Y; Ochi N; Yasuda A; Takahashi H; Wakasugi T; Funahashi H; Sato M; Takeyama H J Surg Res; 2010 May; 160(1):90-101. PubMed ID: 19560785 [TBL] [Abstract][Full Text] [Related]
33. miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway. Zhang X; Shi H; Tang H; Fang Z; Wang J; Cui S Int J Mol Med; 2015 May; 35(5):1301-8. PubMed ID: 25760926 [TBL] [Abstract][Full Text] [Related]
34. Interleukin 7 receptor activates PI3K/Akt/mTOR signaling pathway via downregulation of Beclin-1 in lung cancer. Jian M; Yunjia Z; Zhiying D; Yanduo J; Guocheng J Mol Carcinog; 2019 Mar; 58(3):358-365. PubMed ID: 30362635 [TBL] [Abstract][Full Text] [Related]
35. Ursolic Acid Induces Apoptosis of Prostate Cancer Cells via the PI3K/Akt/mTOR Pathway. Meng Y; Lin ZM; Ge N; Zhang DL; Huang J; Kong F Am J Chin Med; 2015; 43(7):1471-86. PubMed ID: 26503559 [TBL] [Abstract][Full Text] [Related]
36. ILT4 drives B7-H3 expression via PI3K/AKT/mTOR signalling and ILT4/B7-H3 co-expression correlates with poor prognosis in non-small cell lung cancer. Zhang P; Yu S; Li H; Liu C; Li J; Lin W; Gao A; Wang L; Gao W; Sun Y FEBS Lett; 2015 Aug; 589(17):2248-56. PubMed ID: 26149216 [TBL] [Abstract][Full Text] [Related]
37. The PI3K/Akt/mTOR signaling pathway mediates insulin-like growth factor 1-induced E-cadherin down-regulation and cell proliferation in ovarian cancer cells. Lau MT; Leung PC Cancer Lett; 2012 Dec; 326(2):191-8. PubMed ID: 22922215 [TBL] [Abstract][Full Text] [Related]
38. Paradigm of kinase-driven pathway downstream of epidermal growth factor receptor/Akt in human lung carcinomas. Dobashi Y; Suzuki S; Kimura M; Matsubara H; Tsubochi H; Imoto I; Ooi A Hum Pathol; 2011 Feb; 42(2):214-26. PubMed ID: 21040950 [TBL] [Abstract][Full Text] [Related]
39. miRNA-223 is an anticancer gene in human non-small cell lung cancer through the PI3K/AKT pathway by targeting EGFR. Ma HP; Kong WX; Li XY; Li W; Zhang Y; Wu Y Oncol Rep; 2019 Mar; 41(3):1549-1559. PubMed ID: 30747217 [TBL] [Abstract][Full Text] [Related]
40. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Vega F; Medeiros LJ; Leventaki V; Atwell C; Cho-Vega JH; Tian L; Claret FX; Rassidakis GZ Cancer Res; 2006 Jul; 66(13):6589-97. PubMed ID: 16818631 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]